Corroborating this set of results with clinical data, we show that an NGFR gene expression signature predicts resistance to immunotherapy in melanoma patients, again in line with the idea that NGFRhi tumor cells represent a pool of ICB-refractory cells. Here, NGFR is linked to neoplasm.